Biggest News Aggregation in the World
📰 Pitolisant Tablets News

Pitolisant Tablets News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pitolisant Tablets. Real-time updates on events, politics, business and more.

Harmony Biosciences Up 4% On Securing FDA Orphan Drug Designation For Pitolisant

Shares of Harmony Biosciences Holdings, Inc. (HRMY) are up 4% on Thursday after the company's Pitolisant Tablets was granted FDA Orphan Drug designation for the treatment of idiopathic hypersomnia (IH), a rare and chronic neurological disease that is characterized by excessive daytime sleepiness.
Kumar Budur Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Pitolisant Tablets Chief Medical Officer Orphan Drug Designation

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science